Victory Capital Management Inc. decreased its holdings in shares of National Health Investors Inc (NYSE:NHI) by 27.4% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 33,775 shares of the real estate investment trust’s stock after selling 12,727 shares during the quarter. Victory Capital Management Inc. owned about 0.08% of National Health Investors worth $1,673,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the stock. Prudential PLC raised its stake in National Health Investors by 35.3% during the first quarter. Prudential PLC now owns 5,237 shares of the real estate investment trust’s stock valued at $259,000 after purchasing an additional 1,366 shares in the last quarter. Avantax Advisory Services Inc. raised its stake in National Health Investors by 13.0% during the first quarter. Avantax Advisory Services Inc. now owns 5,965 shares of the real estate investment trust’s stock valued at $295,000 after purchasing an additional 684 shares in the last quarter. Robeco Institutional Asset Management B.V. raised its stake in shares of National Health Investors by 9.4% in the first quarter. Robeco Institutional Asset Management B.V. now owns 183,616 shares of the real estate investment trust’s stock valued at $9,092,000 after acquiring an additional 15,831 shares during the period. Janney Montgomery Scott LLC raised its stake in shares of National Health Investors by 17.9% in the first quarter. Janney Montgomery Scott LLC now owns 27,592 shares of the real estate investment trust’s stock valued at $1,366,000 after acquiring an additional 4,182 shares during the period. Finally, Capital Square LLC purchased a new stake in shares of National Health Investors in the first quarter valued at $59,000. 70.53% of the stock is currently owned by institutional investors.

In other National Health Investors news, Director W Andrew Adams bought 27,000 shares of the company’s stock in a transaction on Monday, March 23rd. The shares were bought at an average cost of $36.16 per share, for a total transaction of $976,320.00. Following the acquisition, the director now directly owns 759,784 shares in the company, valued at $27,473,789.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO D. Eric Mendelsohn sold 4,000 shares of the stock in a transaction dated Monday, February 24th. The stock was sold at an average price of $90.58, for a total transaction of $362,320.00. Following the transaction, the chief executive officer now owns 44,256 shares in the company, valued at $4,008,708.48. The disclosure for this sale can be found here. Over the last quarter, insiders have acquired 29,576 shares of company stock worth $1,096,421. 5.74% of the stock is owned by company insiders.

NHI has been the topic of several recent analyst reports. Wells Fargo & Co reduced their target price on shares of National Health Investors from $82.00 to $51.00 and set an “equal weight” rating on the stock in a research note on Thursday, March 26th. Mizuho downgraded shares of National Health Investors from a “buy” rating to a “neutral” rating and reduced their target price for the company from $60.00 to $55.00 in a research note on Friday. SunTrust Banks reduced their target price on shares of National Health Investors from $77.00 to $61.00 and set a “hold” rating on the stock in a research note on Thursday, April 23rd. Berenberg Bank initiated coverage on shares of National Health Investors in a report on Wednesday, February 5th. They issued a “buy” rating and a $94.00 price target on the stock. Finally, ValuEngine cut shares of National Health Investors from a “hold” rating to a “sell” rating in a report on Thursday, April 2nd. Three analysts have rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the stock. National Health Investors currently has an average rating of “Hold” and an average price target of $67.57.

NYSE NHI opened at $52.98 on Friday. The company has a current ratio of 12.05, a quick ratio of 12.05 and a debt-to-equity ratio of 1.03. National Health Investors Inc has a 12 month low of $31.37 and a 12 month high of $91.12. The company’s 50-day moving average price is $50.81 and its 200-day moving average price is $71.49. The stock has a market cap of $2.38 billion, a PE ratio of 12.58 and a beta of 0.85.

National Health Investors (NYSE:NHI) last issued its earnings results on Monday, May 11th. The real estate investment trust reported $1.37 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.40 by ($0.03). National Health Investors had a return on equity of 12.62% and a net margin of 57.16%. The business had revenue of $83.08 million for the quarter, compared to the consensus estimate of $80.77 million. During the same quarter in the previous year, the company earned $1.31 earnings per share. The firm’s revenue was up 9.2% on a year-over-year basis. As a group, sell-side analysts forecast that National Health Investors Inc will post 5.59 earnings per share for the current year.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Featured Story: How do investors use RSI to grade stocks?

Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors Inc (NYSE:NHI).

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.